Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 256.69M | 236.80M | 232.42M | 202.79M | 224.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 256.69M | 236.80M | 232.42M | 202.79M | 224.78M |
| Cost of Revenue | 98.63M | 88.56M | 87.93M | 75.02M | 82.66M |
| Gross Profit | 158.07M | 148.24M | 144.49M | 127.77M | 142.12M |
| SG&A Expenses | 113.86M | 99.47M | 99.35M | 95.34M | 99.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 224.43M | 199.51M | 199.13M | 180.93M | 192.83M |
| Operating Income | 32.26M | 37.28M | 33.29M | 21.86M | 31.95M |
| Income Before Tax | 30.62M | 33.99M | 27.68M | 15.66M | 24.88M |
| Income Tax Expenses | 5.90M | 8.20M | 6.56M | 3.63M | 6.26M |
| Earnings from Continuing Operations | 24.72M | 25.78M | 21.11M | 12.03M | 18.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -319.00K | 81.00K | -203.00K | 131.00K | -413.00K |
| Net Income | 24.40M | 25.86M | 20.91M | 12.16M | 18.21M |
| EBIT | 32.26M | 37.28M | 33.29M | 21.86M | 31.95M |
| EBITDA | 39.11M | 45.12M | 40.92M | 27.81M | 33.40M |
| EPS Basic | 0.06 | 0.06 | 0.05 | 0.03 | 0.04 |
| Normalized Basic EPS | 0.04 | 0.05 | 0.04 | 0.02 | 0.04 |
| EPS Diluted | 0.06 | 0.06 | 0.05 | 0.03 | 0.04 |
| Normalized Diluted EPS | 0.04 | 0.05 | 0.04 | 0.02 | 0.04 |
| Average Basic Shares Outstanding | 420.76M | 431.05M | 418.22M | 434.25M | 413.80M |
| Average Diluted Shares Outstanding | 420.76M | 431.05M | 418.22M | 434.25M | 413.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |